Completed OBSERVATIONAL NCT01334996

Use of Tamoxifen in Systemic Mastocytosis

Treatment of Systemic Mastocytosis With Tamoxifen

Sponsor: Mayo Clinic

Updated 8 times since 2017 Last updated: Apr 9, 2020 Started: Feb 28, 2005 Primary completion: Aug 28, 2019 Completion: Aug 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01334996, this observational or N/A phase trial focuses on Systemic Mastocytosis and remains completed. Sponsored by Mayo Clinic, it has been updated 8 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
May 2020 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Dec 2018 — May 2020 [monthly]

Recruiting

Status: Unknown Status → Recruiting

▶ Show 3 earlier versions

Jun 2018 — Dec 2018 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States